Serum concentrations of risperidone and 9-hydroxyrisperidone after administration of the long-acting injectable form of risperidone: evidence from a routine therapeutic drug monitoring service.

Serum concentrations of risperidone and 9-hydroxyrisperidone after administration of the long-acting injectable form of risperidone: evidence from a routine therapeutic drug monitoring service.

Item
http://www.wikidata.org/entity/Q45234990
Long-acting paliperidone palmitate - interim results of an observational study of its effect on hospitalization.Clinical pharmacology of atypical antipsychotics: an update.Risperidone long-acting injection: safety and efficacy in elderly patients with schizophrenia.Atypical antipsychotics: trends in analysis and sample preparation of various biological samples.Effects of controlled-release formulations of atypical antipsychotics on functioning and quality of life of schizophrenic individuals.Oral versus Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia and Special Populations at Risk for Treatment Nonadherence: A Systematic Review.A systematic review and combined analysis of therapeutic drug monitoring studies for long-acting risperidone.Assessing drug-drug interactions through therapeutic drug monitoring when administering oral second-generation antipsychotics.Plasma levels and estimated dopamine D2 receptor occupancy of long-acting injectable risperidone during maintenance treatment of schizophrenia: a 3-year follow-up study.Clinical response in a risperidone-medicated naturalistic sample: patients' characteristics and dose-dependent pharmacokinetic patterns.Serum Concentrations of Paliperidone after Administration of the Long-Acting Injectable Formulation.Multiple dose pharmacokinetics of risperidone and 9-hydroxyrisperidone in Chinese female patients with schizophrenia.Genome-wide association study identifies common variants associated with pharmacokinetics of psychotropic drugs.
P2860

Serum concentrations of risperidone and 9-hydroxyrisperidone after administration of the long-acting injectable form of risperidone: evidence from a routine therapeutic drug monitoring service.

Item
http://www.wikidata.org/entity/Q45234990
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Serum concentrations of risper ...... eutic drug monitoring service.
@en
Serum concentrations of risper ...... eutic drug monitoring service.
@nl
type
label
Serum concentrations of risper ...... eutic drug monitoring service.
@en
Serum concentrations of risper ...... eutic drug monitoring service.
@nl
prefLabel
Serum concentrations of risper ...... eutic drug monitoring service.
@en
Serum concentrations of risper ...... eutic drug monitoring service.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Serum concentrations of risper ...... eutic drug monitoring service.
@en
P2093
P304
P31
P356
10.1097/00007691-200502000-00019
P433
P478
P50
P577
P698